Aquestive Therapeutics (AQST) Gross Profit (2017 - 2026)
Aquestive Therapeutics (AQST) recorded Gross Profit of $3.95 million in Q3 2026, down 52.4% from $8.3 million a year earlier and down 59.7% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Gross Profit (2017 - 2026) Analysis & Trends
On a TTM basis, Aquestive Therapeutics' Gross Profit came in at $31.91 million as of Sep 30, 2026, up 22.0% year-over-year; for FY2025, it was $25.99 million, down 34.5% from FY2024.
- Annual Gross Profit has a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $39.69 million in FY2024 (+33.4%), $29.75 million in FY2023 (+5.2%), $28.29 million in FY2022 (-21.1%) and $35.84 million in FY2021 (+9.0%).
- The Q3 2026 figure is the lowest quarterly Gross Profit in data going back to Q2 2017.
- On a year-over-year basis, Gross Profit rose in two of the last eight quarters, with growth averaging 2.6%.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 135.1% in Q2 2024, against a decline of 65.1% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $9.8 million (Q2 2026), $10.98 million (Q1 2026) and $7.18 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Aquestive Therapeutics | 442.42 Mn | 21.68 Mn | 3.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.95 Mn |
| Jun 30, 2026 | 9.80 Mn |
| Mar 31, 2026 | 10.98 Mn |
| Dec 31, 2025 | 7.18 Mn |
| Sep 30, 2025 | 8.30 Mn |
| Jun 30, 2025 | 5.44 Mn |
| Mar 31, 2025 | 5.07 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Sep 30, 2024 | 9.11 Mn |
| Jun 30, 2024 | 15.57 Mn |
| Mar 31, 2024 | 7.66 Mn |
| Dec 31, 2023 | 8.53 Mn |
| Sep 30, 2023 | 8.20 Mn |
| Jun 30, 2023 | 6.62 Mn |
| Mar 31, 2023 | 6.40 Mn |
| Dec 31, 2022 | 5.38 Mn |
| Sep 30, 2022 | 6.84 Mn |
| Jun 30, 2022 | 8.02 Mn |
| Mar 31, 2022 | 8.06 Mn |
| Dec 31, 2021 | 7.71 Mn |
API Access
Aquestive Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();